Skip to main content
Hit enter to search or ESC to close
Search
Close Search
Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
Investors
Media Coverage
NASDAQ: ENVB
Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Media Coverage
Joseph Tucker, Ph.D., CEO & Director, Enveric Biosciences [Big4Bio]
July 20, 2026
The Next Evolution of Psychedelic Medicine May Not Be Psychedelic at All [Meditech Today]
July 15, 2026
Psychedelic Nation? Psilocybin Treatments Offer New Hope for People Prozac Hasn’t Helped [The Daily Upside]
July 5, 2026
Trump’s psychedelic drug order boosts investor interest with promise of faster reviews [Reuters]
May 20, 2026
New antidepressants: Tackling treatment resistant depression [LaBiotech]
May 19, 2026
Executive Order For Psychedelics [Clinical Leader]
May 8, 2026
The Neuroplastogen Bet: Inside the Science, the Hype, and the Unanswered Questions in Psychedelic-Inspired Medicine [Meditech Today]
May 6, 2026
Enveric Highlights Preclinical PTSD Data Amid Rising Focus On Mental Health Therapies [Benzinga]
May 5, 2026
PTSD, Policy Shifts, and the Rise of Neuroplastogens: What Enveric’s Latest Data Signals for the Field [Microdose]
May 5, 2026
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map. [Microdose]
April 27, 2026
1
2
3
…
17
›
Close Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
